Ledger.Open graph →
SEC Form D · filed May 13, 2020

Lexaria Bioscience Corp

Offering
$2.0M
Sold
$2.0M
Exemption
Rule 506(b)
Industry
Other
Location
KELOWNA, British Columbia, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Allan Spissinger · KELOWNA, British Columbia, CanadaExecBrian Quigley · KELOWNA, British Columbia, CanadaDirectorNicholas Baxter · KELOWNA, British Columbia, CanadaDirectorJohn Docherty · KELOWNA, British Columbia, CanadaExec · DirectorTed Mckechnie · KELOWNA, British Columbia, CanadaDirectorChristopher Bunka · Vancouver, British Columbia, CanadaExec · DirectorRobert Kennedy · Westport, CTExecJohn Thomas · San Marino, CADirectorAndrew Salter · San Marino, CAExec · DirectorJordan Mikes · Los Angeles, CADirectorBrian Laibow · Los Angeles, CADirectorDavid Hansel · Red Bank, NJDirectorNanco Associates Associates LLC · Clarence, NYDirectorPaul S. Nanula · Clarence, NYDirectorAnthony Nanula · Clarence, NYExecAngel Vazquez · Miguel Hidalgo, CDMX, O5Exec · DirectorChristopher Bunka · Vancouver, British Columbia, CanadaExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗